Amanda Mahan, FNP-C

NPI: 1720562226
Total Payments
$51.74
2023 Payments
$17.13
Companies
1
Transactions
3
Medicare Patients
1,267
Medicare Billing
$51,117

Payment Breakdown by Category

Food & Beverage$51.74 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $51.74 3 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $51.74 3 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $17.13 1 ABBVIE INC. ($17.13)
2021 $34.61 2 AbbVie Inc. ($34.61)

All Payment Transactions

3 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/07/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $17.13 General
Category: NEUROSCIENCE
10/26/2021 AbbVie Inc. VRAYLAR (Drug) Food and Beverage In-kind items and services $17.56 General
Category: NEUROSCIENCE
03/04/2021 AbbVie Inc. UBRELVY (Drug) Food and Beverage In-kind items and services $17.05 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 363 546 $52,226 $15,813
2021 4 129 153 $12,310 $1,999
2020 19 775 1,074 $74,419 $33,305
Total Patients
1,267
Total Services
1,773
Medicare Billing
$51,117
Procedure Codes
35

All Medicare Procedures & Services

35 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 36 95 $12,445 $5,201 41.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 53 53 $10,017 $2,914 29.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 34 34 $10,608 $2,568 24.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 27 $4,779 $2,172 45.4%
87428 Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza Office 2023 28 33 $4,950 $1,251 25.3%
96372 Injection of drug or substance under skin or into muscle Office 2023 44 76 $2,280 $597.04 26.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 32 46 $414.00 $386.40 93.3%
87430 Detection test by immunoassay technique for streptococcus, group a (strep) Office 2023 20 23 $1,081 $378.81 35.0%
J1030 Injection, methylprednisolone acetate, 40 mg Office 2023 24 36 $1,368 $191.14 14.0%
81002 Urinalysis, manual test Office 2023 23 40 $960.00 $136.40 14.2%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 22 37 $2,220 $13.96 0.6%
J1100 Injection, dexamethasone sodium phosphate, 1 mg Office 2023 31 46 $1,104 $3.60 0.3%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 84 100 $9,000 $1,600 17.8%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 14 15 $1,800 $281.51 15.6%
99211 Established patient outpatient visit, minimal presenting problem Office 2021 20 25 $1,250 $88.30 7.1%
81003 Automated urinalysis test Office 2021 11 13 $260.00 $29.25 11.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 219 415 $37,350 $15,228 40.8%
G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit Office 2020 54 54 $10,800 $7,189 66.6%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 31 31 $4,650 $2,808 60.4%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 21 25 $3,000 $1,561 52.0%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 24 24 $2,400 $1,331 55.5%
90756 Vaccine for influenza for injection into muscle Office 2020 31 31 $930.00 $858.70 92.3%
G0008 Administration of influenza virus vaccine Office 2020 52 52 $1,300 $798.20 61.4%
99211 Established patient office or other outpatient visit, typically 5 minutes Office 2020 34 66 $3,300 $733.49 22.2%
87804 Detection test for influenza virus Office 2020 32 34 $1,360 $556.10 40.9%

About Amanda Mahan, FNP-C

Amanda Mahan, FNP-C is a Nurse Practitioner healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2018. The National Provider Identifier (NPI) number assigned to this provider is 1720562226.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Mahan, FNP-C has received a total of $51.74 in payments from pharmaceutical and medical device companies, with $17.13 received in 2023. These payments were reported across 3 transactions from 1 company. The most common payment nature is "Food and Beverage" ($51.74).

As a Medicare-enrolled provider, Mahan has provided services to 1,267 Medicare beneficiaries, totaling 1,773 services with total Medicare billing of $51,117. Data is available for 3 years (2020–2023), covering 35 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Houston, MS
  • Active Since 09/20/2018
  • Last Updated 04/07/2021
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1720562226

Products in Payments

  • UBRELVY (Drug) $34.18
  • VRAYLAR (Drug) $17.56

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Houston